<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00802620</url>
  </required_header>
  <id_info>
    <org_study_id>0616/04</org_study_id>
    <nct_id>NCT00802620</nct_id>
  </id_info>
  <brief_title>Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare amniotic membrane associated with conjunctival&#xD;
      autograft versus conjunctival autograft alone in the treatment of recurrent pterygia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with recurrent pterygia without symblepharon were randomly assigned to undertake&#xD;
      pterygium excision followed by amniotic membrane associated with a small conjunctival&#xD;
      autograft (2x3mm) or conjunctival autograft (approximately 5x8mm) alone. The patients were&#xD;
      examined after 1, 7, 30, 90, 180 and 360 days after the surgery. Recurrence was considered as&#xD;
      a fibrovascular ingrowth of 1.5 mm or more beyond the limbus with conjunctival drag.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>June 2005</start_date>
  <primary_completion_date type="Actual">June 2005</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amniotic membrane treatment for recurrent pterygia</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Recurrent Pterygia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conjunctival autograft versus conjunctival autograft treatment for recurrent pterygia</intervention_name>
    <description>Amniotic membrane Conjunctival autograft Conjunctival autograft Recurrent pterygia</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recurrent pterygium&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 15 year of age&#xD;
&#xD;
          -  Symblepharon&#xD;
&#xD;
          -  Glaucoma,&#xD;
&#xD;
          -  Ocular Allergy&#xD;
&#xD;
          -  Ocular surface disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2008</verification_date>
  <study_first_submitted>December 4, 2008</study_first_submitted>
  <study_first_submitted_qc>December 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2008</study_first_posted>
  <last_update_submitted>December 4, 2008</last_update_submitted>
  <last_update_submitted_qc>December 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2008</last_update_posted>
  <responsible_party>
    <name_title>Jose Alvaro Pereira Gomes</name_title>
    <organization>Department of Ophthalmology, Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil.</organization>
  </responsible_party>
  <keyword>Amniotic membrane</keyword>
  <keyword>Conjunctival autograft</keyword>
  <keyword>Recurrent pterygia</keyword>
  <keyword>compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pterygium</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

